- Home
- ALKS vs CFR Comparison
ALKS vs CFR Comparison
Compare ALKS & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALKS | CFR |
|---|---|---|
| Founded | 1987 | 1868 |
| Country | Ireland | United States |
| Employees | N/A | 6008 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 8.5B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALKS | CFR |
|---|---|---|
| Price | $44.99 | $145.66 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 13 |
| Target Price | $43.43 | ★ $142.31 |
| AVG Volume (30 Days) | ★ 1.8M | 536.3K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,475,899,000.00 | N/A |
| Revenue This Year | $24.26 | $9.72 |
| Revenue Next Year | $4.47 | $4.70 |
| P/E Ratio | ★ N/A | $14.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.17 | $119.00 |
| 52 Week High | $45.76 | $148.97 |
Technical Indicators
Market Signals| Indicator | ALKS | CFR |
|---|---|---|
| Relative Strength Index (RSI) | 70.64 | 60.70 |
| Support Level | $27.65 | $133.49 |
| Resistance Level | N/A | $146.09 |
| Average True Range (ATR) | 1.52 | 2.55 |
| MACD | -0.01 | 0.79 |
| Stochastic Oscillator | 85.02 | 81.66 |
Price Performance
Historical ComparisonAbout ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $52 billion in assets (as of March 2026), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based banking approach that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through targeted branch openings rather than acquisitions. The bank's sweet spot is small to medium-sized Texas-based commercial clients.